Sodium-guided water pill treatment for heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if using urine sodium levels to guide diuretic (water pill) dosing during hospital care for worsening heart failure can improve outcomes. The goal is to help doctors adjust treatment more effectively to clear extra fluid from the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must be in the hospital for worsening heart failure symptoms (like shortness of breath or swelling) that need IV water pills.
- You must have been taking a water pill like furosemide (Lasix) or torasemide (Demadex) for at least 2 days before this hospital stay.
- You must have signs of fluid build-up, such as swelling in legs or fluid in lungs.
- You must not have certain severe conditions, like a recent heart attack, very low blood pressure, or severe kidney failure.
- You must not be pregnant or breastfeeding, and must not have active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to adjust diuretic (water pill) doses based on urine sodium levels in patients hospitalized for worsening heart failure. The goal is to improve fluid removal and get patients home sooner.
This trial uses a simple urine test to see if your current water pill dose is right for you. The goal is to find the best dose to reduce symptoms and avoid hospital visits.
This trial tests a combination of two medicines—a salt solution and a water pill—given in an outpatient clinic to see if it helps people with both heart and kidney problems feel better and manage fluid buildup.
This trial tests whether adding a second type of diuretic (water pill) can help people with heart failure who don't respond well to their current diuretic. It aims to find better ways to manage fluid buildup.
This Phase 1 study looks at why “water pills” (diuretics) like bumetanide may not remove fluid as expected in people with heart failure. The results may help clinicians improve treatment strategies for fluid control in the future.
This trial tests different water pill (diuretic) strategies for people hospitalized with acute heart failure and too much fluid. It is designed for patients who may not respond well to standard water pills, to find a more effective way to relieve symptoms.
Hear when a new Congestion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.